Carregando...
Azacitidine in outpatient treatment – single center experience
AIM OF THE STUDY: Azacitidine is a hypomethylating agent which is used in the treatment of myelodysplastic syndromes, acute myeloid leukemia and chronic myelomonocytic leukemia. Because of good tolerance to the drug, azacitidine can be administered both during hospitalization and in an outpatient se...
Na minha lista:
| Publicado no: | Contemp Oncol (Pozn) |
|---|---|
| Principais autores: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Termedia Publishing House
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4731453/ https://ncbi.nlm.nih.gov/pubmed/26843844 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2015.56653 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|